SK bioscience Co., Ltd. engages in the development and distribution of bio and vaccine products. The company was founded on July 1, 2018 and is headquartered in Seongnam-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 302440 is 50,300 KRW — it has decreased by −4.19% in the past 24 hours. Watch SK BIOSCIENCE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange SK BIOSCIENCE stocks are traded under the ticker 302440.
302440 stock has fallen by −9.04% compared to the previous week, the month change is a 3.50% rise, over the last year SK BIOSCIENCE has showed a −27.73% decrease.
We've gathered analysts' opinions on SK BIOSCIENCE future price: according to them, 302440 price has a max estimate of 60,000.00 KRW and a min estimate of 37,000.00 KRW. Watch 302440 chart and read a more detailed SK BIOSCIENCE stock forecast: see what analysts think of SK BIOSCIENCE and suggest that you do with its stocks.
302440 reached its all-time high on Aug 17, 2021 with the price of 362,000 KRW, and its all-time low was 43,700 KRW and was reached on Nov 18, 2024. View more price dynamics on 302440 chart. See other stocks reaching their highest and lowest prices.
302440 stock is 5.57% volatile and has beta coefficient of 1.34. Track SK BIOSCIENCE stock price on the chart and check out the list of the most volatile stocks — is SK BIOSCIENCE there?
Today SK BIOSCIENCE has the market capitalization of 3.94 T, it has decreased by −1.32% over the last week.
Yes, you can track SK BIOSCIENCE financials in yearly and quarterly reports right on TradingView.
SK BIOSCIENCE is going to release the next earnings report on Mar 25, 2025. Keep track of upcoming events with our Earnings Calendar.
302440 earnings for the last quarter are −290.52 KRW per share, whereas the estimation was −318.43 KRW resulting in a 8.76% surprise. The estimated earnings for the next quarter are −426.94 KRW per share. See more details about SK BIOSCIENCE earnings.
SK BIOSCIENCE revenue for the last quarter amounts to 94.32 B KRW, despite the estimated figure of 94.00 B KRW. In the next quarter, revenue is expected to reach 89.00 B KRW.
302440 net income for the last quarter is −22.32 B KRW, while the quarter before that showed −11.41 B KRW of net income which accounts for −95.61% change. Track more SK BIOSCIENCE financial stats to get the full picture.
No, 302440 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 1.09 K employees. See our rating of the largest employees — is SK BIOSCIENCE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SK BIOSCIENCE EBITDA is −86.36 B KRW, and current EBITDA margin is −2.37%. See more stats in SK BIOSCIENCE financial statements.
Like other stocks, 302440 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SK BIOSCIENCE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SK BIOSCIENCE technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SK BIOSCIENCE stock shows the sell signal. See more of SK BIOSCIENCE technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.